Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Catalyst Pharmaceutical Partners Company Profile (NASDAQ:CPRX)

Consensus Ratings for Catalyst Pharmaceutical Partners (NASDAQ:CPRX) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $3.41 (50.33% upside)

Analysts' Ratings History for Catalyst Pharmaceutical Partners (NASDAQ:CPRX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/14/2014Piper JaffrayInitiated CoverageOverweight$4.00ViewTweet This Rating  Share This Rating on StockTwits
4/14/2014Piper JaffrayReiterated RatingOverweight$4.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2014AegisReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
1/8/2014AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
11/19/2013ZacksDowngradeOutperform -> Neutral$1.90ViewTweet This Rating  Share This Rating on StockTwits
10/21/2013AegisBoost Price TargetBuy$4.00 -> $5.50ViewTweet This Rating  Share This Rating on StockTwits
10/18/2013ZacksUpgradeNeutral -> Outperform$3.10ViewTweet This Rating  Share This Rating on StockTwits
10/16/2013ZacksReiterated RatingHold$1.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2013Roth CapitalBoost Price Target$2.75 -> $3.75ViewTweet This Rating  Share This Rating on StockTwits
9/24/2013Maxim GroupInitiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
9/6/2013AegisBoost Price TargetBuy$3.50 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2013ZacksReiterated RatingHold$1.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2013AegisBoost Price TargetBuy$3.00 -> $3.50ViewTweet This Rating  Share This Rating on StockTwits
8/16/2013AegisReiterated RatingBuy$2.50 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
6/4/2013ZacksDowngradeOutperform -> Neutral$1.00ViewTweet This Rating  Share This Rating on StockTwits
4/18/2013AegisInitiated CoverageBuy$2.50ViewTweet This Rating  Share This Rating on StockTwits
8/27/2012Rodman & RenshawUpgradeMarket Perform -> Outperform$3.70ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2012 forward)